Home›Search›CNS Oncology

CNS Oncology

Taylor and Francis Ltd. · United Kingdom · Est. 1985

ISSN2045-0915

SJR Q2✓ Scopus / SJR✓ DOAJ✓ Open Access

/ 100

High Trust

PubScope credibility score from verifiable indexing & ethics signals

Score Breakdown

◆ Scopus Q266

✓ Corroboration (2 more)+12

Total78

Third-party records · how this is calculated · Report an error →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

202

days submission → published

measured · last 16 articles · accept 192d

weeks to publish · journal-reported

Average · vs ~15 wk median

SJR Rank

Top 50% in field

Journal Impact Factor

Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals. If this journal has one, it appears on the journal’s page ↗

SJR Scorei

0.992

H-Indexi

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIPi

1.124

Total Worksi

409

Total Citationsi

7,092

2yr Mean Citednessi

2.86

Open Impact Factor alternative

Aims & Scope

Subject areas: Neurology; Neurology (clinical).

General Information

Country / RegionUnited Kingdom

Primary LanguageEnglish

1st Year Published1985

FrequencyFour Issues Per Year, 2016-

StatusActive (last: 2025)

Total Publications409

Publisher OrgFuture Medicine

OA Since2017

Visit Journal Website

Submission Info

Peer ReviewDouble-blind

Review Time~13 weeks

Acceptance Rate—

OA LicenseCC BY-NC

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Plagiarism Detection✓ Yes

📦 Long-term Preservation

LOCKSSPMCCLOCKSS

Think.Check.Submit Compliance

thinkchecksubmit.org

10/12 · 83%

✅

Do you know the journal / publisher?

Taylor and Francis Ltd.

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2045-0915

✅

Indexed in a trusted database?

Scopus, DOAJ, PubMed

✅

Peer review process documented?

Double-blind

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

✅

Long-term digital preservation?

LOCKSS, PMC, CLOCKSS

✅

Plagiarism detection in place?

Yes

✅

Listed in DOAJ (verified OA)?

DOAJ verified

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

818

2019

245

2020

315

2021

209

2022

2023

2024

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

NeurologyQ2

Neurology (clinical)Q2

Subject Classification

Scopus Categories

Neurology (clinical)Neurology

Research Topics (OpenAlex)

Glioma Diagnosis and TreatmentBrain Metastases and TreatmentMeningioma and schwannoma managementNeuroblastoma Research and TreatmentsCancer, Hypoxia, and MetabolismLung Cancer Research StudiesManagement of metastatic bone diseaseCNS Lymphoma Diagnosis and TreatmentNeurofibromatosis and Schwannoma CasesLymphoma Diagnosis and Treatment

Frequently asked questions about CNS Oncology

Is CNS Oncology a predatory journal?

PubScope has no integrity flags on record for CNS Oncology: it is indexed in Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 78/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of CNS Oncology?

CNS Oncology is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor. Its SCImago SJR score is 0.992.

Is CNS Oncology indexed in Scopus and Web of Science?

CNS Oncology is indexed in Scopus, DOAJ.

What is the aims and scope of CNS Oncology?